2024
Dexcom celebrates funded access to life-changing diabetes technology for all New Zealanders with Type 1 diabetes
AUCKLAND, New Zealand – October 1, 2024: DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, commends Pharmac’s decision to fund continuous glucose monitors (CGM) and compatible insulin pumps and consumables for all New Zealanders living with Type 1 diabetes. Kirstin Brown, New Zealand Country Manager at Dexcom …
02.10.2024
Pharmac’s public consultation announcement is one step closer for Type 1 diabetes community
AUCKLAND, New Zealand – 3 April 2024: Dexcom Inc. (Nasdaq: DXCM), is excited about Pharmac’s latest announcement today regarding the consultation process for Continuous Glucose Monitoring (CGM) and Insulin Pump funding in New Zealand – we are so close to people with T1D in NZ getting access to (CGM) systems! Kirstin Brown, Country Manager at …
03.04.2024